Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622

Overview of attention for article published in Breast Cancer Research and Treatment, July 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,641 followers.

Phase II Studies of Two Different Schedules of Dasatinib in Bone Metastasis #BreastCancer @FredHutch https://t.co/HdhpmN4I7x

Phase II studies of two different schedules of dasatinib in ***bone metastasis predominant metastatic… https://t.co/lJic8Ap00v #breastcancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.